Varnes M E, Bayne M T, Bright G R
Department of Radiology, Case Western Reserve University School of Medicine/University Hospitals of Cleveland, OH, USA.
Photochem Photobiol. 1996 Nov;64(5):853-8. doi: 10.1111/j.1751-1097.1996.tb01846.x.
Previous studies showed that photodynamic therapy (PDT) sensitized by aluminum phthalocyanine can be dramatically potentiated by the K+/H+ ionophore nigericin. Nigericin equilibrates intracellular pH (pHi) and extracellular pH (pHe) and is most effective in potentiating PDT damage when cells are in an acidic environment (pH 6.5-6.7). We therefore hypothesized that the ability of nigericin to lower pHi is causally related to its ability to potentiate PDT. To test this, the pHi of A549 cells was reduced using pHe-adjusted growth medium, with or without addition of amiloride and 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid, inhibitors of the membrane-based exchangers responsible for regulating pHi. Using fluorescence ratio imaging, we found that pHi can be equilibrated to within +/- 0.05 pH unit, in the pH range of 6.0-6.8, for up to 1 h after pHe adjustment. Cells equilibrated to various pHi were subjected to PDT at various light fluences, then plated for clonogenic survival immediately after PDT treatment. There is no significant effect of lowering pHi, to values as low as 6.23, on the toxicity of PDT, regardless of whether pHi is lowered by adjustment of the medium alone or by addition of exchange inhibitors. However, cells equilibrated to pHi 6.0 are more sensitive to PDT, with survival reduced by 1 log at 20 kJ/m2 and 1.5 log at 30 kJ/m2, relative to cells treated at a pHi of 6.8 (controls). In contrast, 20 microM nigericin in medium at pHe 6.7 reduces pHi to 6.55, but reduces the surviving fraction at 20 kJ/m2 by nearly 3 logs relative to controls. These data conclusively demonstrate that the ability of nigericin to potentiate PDT is not directly related to its ability to lower pHi. Furthermore, they show that the expression of PDT damage is independent of pHi, except at the very low value of 6.0. Photodynamic therapy does not induce apoptosis in A549 cells, at surviving fractions of 0.1 to 0.01, under any of the treatment conditions used in this study.
先前的研究表明,用铝酞菁敏化的光动力疗法(PDT)可被钾离子/氢离子载体尼日利亚菌素显著增强。尼日利亚菌素可平衡细胞内pH值(pHi)和细胞外pH值(pHe),并且当细胞处于酸性环境(pH 6.5 - 6.7)时,其在增强PDT损伤方面最为有效。因此,我们推测尼日利亚菌素降低pHi的能力与其增强PDT的能力存在因果关系。为了验证这一点,使用经pHe调节的生长培养基降低A549细胞的pHi,添加或不添加amiloride和4,4'-二异硫氰酸根合芪-2,2'-二磺酸,这两种物质是负责调节pHi的基于膜的交换体的抑制剂。通过荧光比率成像,我们发现,在调节pHe后长达1小时内,在6.0 - 6.8的pH范围内,pHi可平衡至±0.05 pH单位内。将平衡至不同pHi的细胞在不同光通量下进行PDT处理,然后在PDT处理后立即接种进行克隆形成存活实验。将pHi降低至低至6.23的值,对PDT的毒性没有显著影响,无论pHi是仅通过调节培养基还是通过添加交换抑制剂来降低。然而,平衡至pHi 6.0的细胞对PDT更敏感,相对于在pHi 6.8(对照)处理的细胞,在20 kJ/m2时存活率降低1个对数,在30 kJ/m2时降低1.5个对数。相比之下,在pHe 6.7的培养基中20 microM的尼日利亚菌素将pHi降低至6.55,但相对于对照,在20 kJ/m2时存活分数降低近3个对数。这些数据确凿地证明,尼日利亚菌素增强PDT的能力与其降低pHi的能力没有直接关系。此外,它们表明,除了在非常低的6.0值时,PDT损伤的表达与pHi无关。在本研究使用的任何处理条件下,光动力疗法在存活分数为0.1至0.01时均不会诱导A549细胞凋亡。